Universal variable fragments

Abstract

Methods and kits for analyzing a subject's genomic DNA to determine the subject's lineage. The methods comprise providing oligonucleotide primers for use in nucleic acid amplifications on a subject's genomic DNA. A first oligonucleotide primer includes a repeat sequence and at least one non-repeat nucleotide located on its 5′ end. A second oligonucleotide primer starts within an amplification-permissive genetic distance on the 3′ side of the repeat sequence in the subject's genomic DNA and may include an a-selective base, such as inosine. Additional oligonucleotide primers may be provided. The methods further comprise conducting nucleic acid amplifications on the subject's genomic DNA using the oligonucleotide primers of the invention to produce amplified DNA fragments based on repeat sequences found at the 5′ end of the subject's genomic DNA and analyzing such amplified DNA fragments to determine the length of repeat sequences found in the subject's genomic DNA.

Description

RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 09/958,221, filed Apr. 15, 2002, now U.S. Pat. No. ______, issued, ______, 2003, which is a national stage of international application PCT/NL01/00177, filed Mar. 5, 2001.

TECHNICAL FIELD

The invention relates generally to methods and materials for the genetic analysis of a subject.

BACKGROUND

For some species, reliable, simple technologies are available for genetic analysis of individuals. However, for most animal and bird species, genetic information is insufficient for applied genetics. Developing existing technologies for each species to obtain genetic data will be extremely laborious and time consuming. Progress to date has been slow. The situation is particularly problematic in the area of wildlife management. For example, building DNA patterns of hawks is currently almost impossible. At the same time, there have been reports of people illegally placing eggs from wild mating hawk couples in tamed breeding hawk nests. It is currently nearly impossible to prove fraud using DNA data in species where genetic variation has not been previously described.

Other areas of interest are DNA identification of exotic species (e.g., animals, plants, organisms) for various reasons. For instance, animals arriving through veterinary control can be identified by sampling them both at departure and at arrival. Using the animal's individual DNA to identify it, animals can be tracked, and proof of their origin is always possible.

Furthermore, parentage verification in rare, expensive animals and strain identification of plants can be performed for any given combination or species. Reports have been made of selling the offspring of “lower” breeding parents as the highest possible quality been made of selling the offspring of “lower” breeding parents as the highest possible quality animals.

Another problem is the determination of sex. For many exotic species, genetic markers are not available to perform sex determination.

A need exists for a method of quickly genetically analyzing a species to determine, among other things, its lineage, sex, and origin.

BRIEF SUMMARY OF THE INVENTION

The invention provides a new technology which has been developed for the quick genetic analysis of a species and individuals thereof. The method includes the use of first and second oligonucleotide primers for performance of PCR amplification on the genomic DNA. The first oligonucleotide primer is a 5′ variation generator, including a repeat sequence and at least one non-repeat nucleotide. The second oligonucleotide primer is a 3′ fragment generator starting within such a genetic distance that amplification of the genomic DNA can be performed and preferably includes inosine. PCR amplification of the genomic DNA is conducted at a relatively low annealing temperature using both the first and second oligonucleotide primers under conditions such that essentially neither the first nor the second oligonucleotide primer alone can amplify sufficient DNA to be detected. DNA fragments are thus produced based on repeat sequences on one end of the genomic DNA, and other sequences based on the opposite end of the genomic DNA. The resulting PCR products can then be analyzed for the length of a repeat sequence found in the genome. A second PCR is preferably conducted on the diluted PCR products of the first PCR. Such a second PCR would be conducted using third and fourth oligonucleotide primers. The third and fourth oligonucleotide primers are elongated versions of the first and second oligonucleotide primers, respectively, thus enabling PCR amplification at relatively higher annealing temperatures and enabling a selection of a sub-set of the DNA fragments amplified in the first PCR. At any point, an optional but preferred restriction digestion may be conducted. The technology has been developed for the quick genetic analysis of a species which is reliable, reproducible, simple, and useful for all species/organisms (e.g., animal, avian, bacterial, viral, and plant). The invention particularly relates to samples obtainable from non-human species but is applicable to samples obtained from humans as well. Neither variation in genome length nor genome composition appears to influence or limit the characteristics of the technology. This new technology is generally reliable, reproducible, simple, and useful for all species/organisms (e.g., animal, avian, bacterial, viral, and plant). Furthermore, any material containing DNA (e.g., blood, hair follicles, etc.) can be used as a source for the generation of DNA patterns.

In one aspect, the invention includes a method of analyzing genomic DNA in a sample. This method includes providing first and second oligonucleotide primers, wherein the first oligonucleotide primer is a “5′ variation generator” comprising a repeat sequence and at least one non-repeat nucleotide on the first oligonucleotide's 5′ end. Meanwhile, the second oligonucleotide primer is a “3′ fragment generator” starting within such a genetic distance that amplification of the genomic DNA can be performed. A nucleic acid amplification such as a polymerase chain reaction (“PCR”) amplification is conducted on the genomic DNA in the sample using both the first and second oligonucleotide primers. The nucleic acid amplification is conducted under conditions such that neither the first nor the second oligonucleotide primer alone amplifies DNA, thus producing DNA fragments based on repeat sequences on one end of the genomic DNA and other sequences based on the opposite end of the genomic DNA. The amplified products are then analyzed to determine the length of a repeat sequence found in the genomic DNA, which can be compared with the DNA putatively of the same individual or the DNA of the individual's putative ancestors or relatives.

Alternatively, and as more thoroughly described hereinafter, multiple amplifications and/or restriction digestion might also be used with the technique.

As described herein, the first primer, the “5′ variation generator,” includes a complementary repeat sequence and at least one non-repeat nucleotide so as to start the amplification at a repeat sequence of the genomic DNA.

By localizing the 5′ variation generator at the 5′ site of repeat sequences, the repeat length variation is enclosed in the amplification rounds. Primers are thus bound to hybridize at the 5′ ends of repeat sequences by addition of one or more nucleotides at the end of the primer.

While the oligonucleotide primers at repeat sequences provide detection of genetic variation, the 3′ fragment generator is used to amplify fragments of reasonable sizes (e.g., 100 base pairs to 10,000 base pairs). The 3′ fragment generator starts within such a genetic distance that amplification of a sample DNA can be performed and preferably includes inosine or another a-selective base allowing it to influence annealing temperatures without coincident or equal influence on the stringency of the annealing reaction. The 3′ fragment generator is designed to anneal to the DNA within a short distance, as mentioned before. To do this, the number of selective nucleotides is kept at a low number, whereas the annealing temperature is influenced by a number of non-selective nucleotides, such as inosines, universal bases, and any combination of A, C, G or T (e.g., R, Y, N). By using such a 3′ fragment generator, the invention provides optimal reaction conditions in the reaction that are generally well suited to the reaction conditions required for the 5′ generator. In short, the number of selective nucleotides of this primer is maintained at a relatively low number, whereby the annealing temperature is raised to enable reliable and reproducible amplification using a-selective bases, such as inosines, in the fragment generator oligonucleotide.

Some of the genetic markers identified using the technology will be located on the male and female sex chromosomes. After the identification of such markers, these markers can be used to determine the sex of species which are difficult to establish through phenotypic characteristics (e.g., porcupine or crocodile).

The invention also includes a kit of parts for performing the genetic analysis and a method of manufacturing such kit for use in genetic analysis. The invention is further described in the detailed description without limiting the invention thereto.

BRIEF DESCRIPTION OF THE DRAWINGS

The samples used in the illustrations are based on high molecular weight DNA obtained from blood samples from each animal.

FIG. 1 illustrates the analyses of five species. Clear differences are present. Different lanes present 1) horse, 2) parrot, 3) cattle, 4) ostrich and 5) pig. The illustration shows DNA fragments ranging from sizes between 100 and 1200 bp.

FIG. 2 is an illustration of the analyses of five species. Clear differences are present. Different lanes present 1) horse, 2) parrot, 3) cattle, 4) ostrich and 5) pig. The illustration shows DNA fragments ranging from sizes between 250 and 300 bp.

FIG. 3 depicts the variation within species. Two samples of the same species (ostrich) are presented. At least three loci are presented.

DETAILED DESCRIPTION OF THE INVENTION

To combine the amplification of many DNA fragments with the selection of a specific set of informative DNA fragments, a preferred protocol is used which is based on two subsequent PCR amplifications. PCR is one of many well-known amplification methods known in the art and is, therefore, not described further here.

In a preferred method, genomic DNA from the sample is amplified in a first PCR at relatively low annealing temperatures. The 5′ variation generator and the 3′ fragment generator are used to generate fragments of which a selected part is to be used in a second PCR. The first PCR is usually run under conditions under which neither the 5′ variation generator nor the 3′ fragment generator alone amplify DNA. Thus, when DNA amplification is performed using both the 5′ variation generator and the 3′ fragment generator, many resulting fragments are based on repeat sequences on one end of the genomic DNA and, at the same time, many sequences are based on an opposite end of the genomic DNA.

After possible dilution of the PCR products of the first PCR, a second PCR is preferably performed. This second PCR is conducted using third and fourth oligonucleotide primers. The third and fourth oligonucleotide primers are commonly elongated versions of the first and second oligonucleotide primers, respectively, thus enabling PCR amplification at relatively higher annealing temperatures and enabling a selection of a sub-set of the DNA fragments amplified in the first PCR. The fourth oligonucleotide primer preferably includes inosine residues.

At any point during this procedure, a preferred, but optional, restriction digestion may take place. Another source of genetic variation in amplified fragments is the presence or absence of restriction sites. Addition of a restriction digest after the second PCR increases the number of genetic polymorphisms detected. Furthermore, the sizes of the DNA fragments to be analyzed for their length are decreased as well.

The amplified PCR products can then be analyzed using a variety of existing methods.

As can be determined, many DNA fragments are amplified in the first PCR amplification, whereas a subset of these DNA fragments are multiplied in the second PCR amplification. Both reactions are preferably run under stringent conditions. Primers used in the PCR procedure can vary in length. Lengths between 4 and 50 nucleotides or inosines were used in the examples.

Primer Design

As previously identified, the variation generator starts at a repeat sequence, while the fragment generator starts within such a genetic distance that amplification of the DNA can be performed.

For the 5′ variation generator, repeat sequences exist throughout any genome in many variations, such as mononucleotide (A, G, C or T) repeat, dinucleotide (CT, CA, CG, AT, AC, AG, GT, GC, GA, TA, TG and TC) repeat, trinucleotide (e.g., TGA, CTG, etc.) repeat, tetranucleotide (e.g., TGCA, CTGT) repeat, and so forth. For instance, an AC repeat can have the structure: CACACACACACA (SEQ ID NO:1) (“6-repeat”), or CACACA (SEQ ID NO:2) (“3-repeat”).

Repeat sequences, of course, also exist in the as yet unanalyzed genomes of species. Repeat sequences exhibit different lengths due to the number of repeats present. For different individuals, differences exist in the numbers of repeats in each locus (“microsatellite”). Thus, genetic variation in repeat sequences can be determined based upon length variation caused by the number of nucleotide repeats in a locus. The number of repeats in a microsatellite can vary enormously with different individuals of the species. Many sequences contain a few repeats (e.g., 2 or 3), whereas some repeats are known to include thousands of base pairs (“bp”).

By localizing the oligonucleotide primer at the 5′ site of repeat sequences, as described herein, the repeat length variation is enclosed in the amplification rounds which are part of PCR. Primers are forced to hybridize at 5′ ends of repeat sequences by adding one or more nucleotides which do not continue the repeat pattern at the 5′ end of the primer. This result is due to the nature of the amplifying enzyme, which elongates DNA fragments starting from the 3′ end of oligonucleotide primers.

While the choice of oligonucleotide primers at repeat sequences provides most of the detection of genetic variation, the 3′ fragment generator is essentially used to amplify fragments of reasonable sizes (100 bp to 10,000 bp).

The number of selective oligonucleotides of the primer is maintained at a low number. At the same time, the annealing temperature is raised to enable reliable and reproducible amplification. This is done using inosine substitutions in the fragment generator. Inosines are used to increase annealing temperatures without affecting the binding conditions of oligonucleotides. Inosines match to any of the four nucleotides in the DNA. When inosine is substituted for a nucleic acid, it contributes to the sensitivity of the technique.

PCR

To combine the amplification of many DNA fragments with the selection of a specific set of informative DNA fragments, a protocol is used which is based on two subsequent PCR amplifications. In the first PCR amplification, many DNA fragments are amplified, whereas in the second PCR amplification, a subset of these DNA fragments are multiplied. Both reactions are run under stringent conditions.

After the PCR (or PCRs) have been conducted, the resulting amplified fragments are preferably subjected to restriction digestion to determine the presence or absence of restriction sites. Use of the restriction enzymes increases the number of genetic polymorphisms detected.

The (preferably digested) product is then sequenced using techniques known in the art to determine the particular genetic patterns or markers present, when so desired.

Applications

The nature of universal variable fragments (UVF) combines flexibility and reproducibility with high levels of polymorphisms. The 5′ variation generator (based on the microsatellite sequence) mostly corresponds with the genetic variation typically found in microsatellites, whereas the 3′ fragment generator is mainly linked to presence/absence polymorphisms. This strategy is typically based on the use of two different fluorescent labels-one associated with the 5′ variation generator, the other corresponding to the 3′ fragment generator. This concept enables the optimal use of high throughput analysis systems based on multiple fluorescent dyes.

In comparison with other technologies, e.g. AFLP, UVF has an increased power to generate polymorphisms in search for high marker density. One distinct advantage of the UVF system is found in the possibility to increase the marker density in regions of chromosomes of specific interest by choosing the order of the bases of the 3′ fragment generator, instead of random, in the flanking region of a known genetic marker. As a result, a number of genetic markers can be identified within a short distance from, e.g., QTL markers. This prospect is not possible with other technologies such as AFLP (and SAMPL), or ISSR (Inter Simple Sequence Repeat).

Compared to several technologies, UVF is different:

a) The power to generate polymorphisms is much larger compared to RAPD (random amplified polymorphism detection). Due to its concept of a three-step strategy, UVF has increased power to generate polymorphisms. RAPD is based on only one primer in just one PCR, whereas UVF is typically based on two consequent PCR amplifications, followed by a digestion step.

b) Amplification using ISSR (Inter Simple Sequence Repeat) is based on one primer in one PCR reaction. UVF is completely different based on typically two PCR amplifications and the use of a digestion step.

c) Amplified Fragment Length Polymorphisms (AFLP) is based on the use of adaptor ligation to initiate PCR. This procedure is typically completely absent in UVF, as is the obligation to start the reaction with a digestion of several restriction enzymes.

d) SAMPL is completely based on AFLP, but is directed to the detection of microsatellites using the AFLP technology.

Furthermore, compared to RAPD and microsatellite analysis, the power of the present invention to generate large amounts of polymorphisms from a small amount of genomic DNA is clear.

Several areas for applications based on UVF include:

1. Gene Hunting

The detection and identification of genetic markers for diseases or beneficial genetic characteristics is possible using UVF. Due to its effectiveness, even in species with a relatively well-developed genetic map, UVF is useful. In other species where the number of available genetic markers is low, UVF will be the technology of choice.

2. Marker Density

In situations where QTL analysis has revealed a genetic marker (e.g., RFLP or microsatellite) with known sequence, the number of markers in a defined region can be increased using the UVF technology. This can be achieved by locating the nine bases of the 3′ fragment generator in the flanking region of the polymorphic marker. This enables generation of genetic markers in specific areas of interest. Using this approach, the range in which QTLs may be located can be decreased, and, for example, “candidate gene approach” can be more directed.

This strategy can be further used to detect genetic variation in the genomic regions close to promoter sites located close to genes. The design of the 3′ fragment generator can be based on general promoter sites or on sequences recognized by transcription factors. This further illustrates the power of UVF over other available technologies.

3. Forensic Analysis

Due to the nature of UVF, small quantities of DNA can be used to generate DNA profiles. This enables the use of UVF in situations where only limited amounts of DNA are available for genetic analysis, e.g., forensics.

4. Biodiversity

UVF enables the search for breed- and species-specific markers. Among other issues, (sub)-species identification of, for example, birds will solve many enduring discussions.

In use, the invention is quite straightforward. The invention provides rapid and straightforward identification of endangered animals and plants. Many wildlife species, both animals and plants, are protected by law. Only limited numbers of individuals may be kept in private. However, identification and lineage of these individuals needs to be proven to effectively protect the law. The invention provides the means to answer any question in wildlife management relating to identity or lineage, also of species of which specific sequences are little known. The invention also provides genetic maps of a species. In some species, genetic information, and certainly genetic maps, are underdeveloped. Usually, identification of genetic markers is time and labor consuming using the existing methodologies (e.g. microsatellites).

Furthermore, testing of these markers is inefficient due to the low number of genetic markers amplified in one, single reaction.

With this new technology, genetic markers are developed at low cost with high speed and efficiency. Thus, “classical” laborious methods are no longer needed and no individual primer sets for each marker is needed. Furthermore, using the invention, many genetic markers can be identified and analyzed in a short period of time. Further analysis of the segregation of these markers in families where diseases, resistance genes, or other genes of interest are segregating as well will enable the identification of genetic markers related to the genes of interest.

In the case where lineage is in question, once the genetic markers of the individual have been determined, they can likewise be determined for the putative parents. The sets of markers (e.g., the number of repeats in a locus, the length variation of the set of amplified fragments, and so on) from an individual can then be compared with the markers of the putative parent or parents, and a determination of lineage made. In the case of the aforementioned hawk, for instance, if the number of repeats in a particular locus of the hawks' DNA do not match that of the tamed breeding putative parents, the conclusion can be drawn that the tamed breeding pair are not the parents.

The same situation arises when the question of pedigree arises. The genetic markers of the individual are compared and contrasted with those of the putative ancestors or relatives, especially parents.

In the case of gender determination, a library would first be constructed of the particular species (e.g., crocodile) with particular emphasis put on the Y chromosome. Once conserved genetic markers present on the Y chromosome are identified for the species, the DNA of the individual in question can be analyzed with the instant invention.

When the question centers around whether or not an individual of a species is the same individual previously tested (e.g., by a nation's health, agricultural, or racing authorities), the individual is tested at a different time, and the results are compared with those of the earlier analysis.

A kit of parts for use with the invention includes first and second oligonucleotide primers for performance of the first polymerase chain reaction amplification on the genomic DNA of the individual. The first oligonucleotide primer is a 5′ variation generator, starting at a repeat sequence. The second oligonucleotide primer is a 3′ fragment generator starting within such a genetic distance that amplification of the genomic DNA can be performed. The kit will also preferably include components for performing the second PCR. Such components include third and fourth oligonucleotide primers, wherein the third oligonucleotide primers is an elongated version of the 5′ variation generator, and the fourth oligonucleotide primers is an elongated version of the 3′ fragment generator. The kit of parts further also preferably includes appropriate restriction enzymes.

The invention is further explained by use of the following illustrative examples. In the examples, only a limited number of primers are shown. However, any combination of primers based on the information presented herein is considered to be using the same principles of this technology.

EXAMPLES

Example I

Primer Design

Using the previously described criteria (e.g., starting at a repeat sequence and localizing the variation generator oligonucleotide primer at the 5′ site of repeat sequences, and starting within a genetic distance), the hereinafter described examples of feasible primer sequences were determined. As can be seen, the 5′ (left) end of the variation generator includes a nucleotide which is not consistent with the existing repeat pattern of the repeat sequence.

PCR 1. Variation Generator.

TTGTGTGTG  (SEQ ID NO:3)
ATGTGTGTG  (SEQ ID NO:4)
CTGTGTGTG  (SEQ ID NO:5)
CCACACACA  (SEQ ID NO:6)
GCACACACA  (SEQ ID NO:7)
TCACACACA  (SEQ ID NO:8)
TTTGTGTGTG (SEQ ID NO:9)
ATTGTGTGTG (SEQ ID NO:10)

Fragment Generator.

ATGTIIIIIT (SEQ ID NO:11)
ATGTCIIIIT (SEQ ID NO:12)
ATGTCTIIIT (SEQ ID NO:13)
TIIITGTCAG (SEQ ID NO:14)
TLIIACGTCG (SEQ ID NO:15)

PCR 1. Amplification of Many Fragments

Genomic DNA taken from a sample was amplified in a first PCR at low annealing temperatures (for example, 30-65° C., but preferably lower than temperatures used at an optional second round of amplification). The previously described oligonucleotide primers were used to generate fragments. The first PCR was run under conditions where neither the fragment generator primer nor the variation generator primer alone could amplify DNA.

PCR 2. Amplification of a Subset of PCR 1.

After dilution of the PCR products of the first PCR, a second PCR was conducted using the resulting fragments. This second PCR was based on the hereinafter described fragment and variation generators which, as can be seen, were elongated to enable PCR amplification at higher annealing temperatures (40-70° C.). This enabled the selection of a subset of the DNA fragments amplified in PCR 1.

Examples of the elongated primer sequences:

PCR 2. Variation Generator.

TTGTGTGTGTGTGTGTG (SEQ ID NO:16)
ATGTGTGTGTGTGTGTG (SEQ ID NO:17)
CTGTGTGTGTGTGTGTG (SEQ ID NO:18)
CCACACACACACACACA (SEQ ID NO:19)
GCACACACACACACACA (SEQ ID NO:20)
TCACACACACACACACA (SEQ ID NO:21)

Fragment Generator. Six Examples are Shown:

ATGTIIIIITIIIIT  (SEQ ID NO:22)
ATGTCIIIITIIIITA (SEQ ID NO:23)
TIIITGTCAGLIIA   (SEQ ID NO:24)
TIIITGTCAGIIIAA  (SEQ ID NO:25)
TIIIACGTCGIIIA   (SEQ ID NO:26)
TIIIACGTCGIIIAA  (SEQ ID NO:27)

The thus amplified PCR products were digested with restriction enzymes such as BamHI or HinfI increasing the number of genetic polymorphisms detected and reducing the sizes of the DNA fragments to be analyzed.

Analysis

Analysis of the digested product was conducted on an ABI 377 sequencer (Perkin Elmer, Calif., USA). The detection on this sequencer was made possible through the use of fluorescently labeled primers; both the 5′ variation generator and the 3′ fragment generator were labeled with different dyes (such as FAM, HEX).

Analysis of the various fragment sizes was performed using the software GENESCAN™ and GENOTYPER™ (both from Perkin Elmer, Calif., USA).

Claims

1-5. (canceled)

6. A method of determining the lineage of an individual by analyzing genomic DNA in a biological sample of the individual, said method comprising:

analyzing said genomic DNA in said biological sample to determine the presence of a repeat sequence;

determining the repeat sequence's length in number of nucleic acids; and

comparing the repeat sequence's length with a corresponding repeat sequence length of a putative ancestor of said individual.

7. The method according to claim 6 wherein the analysis of said genomic DNA in said sample comprises using a first oligonucleotide primer for performing a first amplification on said genomic DNA, said first oligonucleotide primer being a 5′ variation generator and comprising a repeat sequence and at least one non-repeat nucleotide on the first oligonucleotide's 5′ end.

8. A kit of parts for analyzing genomic DNA in a sample, said kit of parts comprising:

first and second oligonucleotide primers for performance of a first nucleic acid amplification on said genomic DNA, said first oligonucleotide primer being a 5′ variation generator, and comprising a repeat sequence and at least one non-repeat nucleotide on the first oligonucleotide's 5′ end, and said second oligonucleotide primer being a 3′ fragment generator.

9. The kit of parts of claim 8 further comprising:

third and fourth oligonucleotide primers, said third oligonucleotide primer comprising the oligonucleotide sequence of said first oligonucleotide primer together with further nucleotides, and said fourth oligonucleotide primer comprising the oligonucleotide sequence of said second oligonucleotide primers together with further nucleotides.

10. The kit of parts of claim 8 further comprising at least one restriction enzyme.

11-13. (canceled)

14. A method for determining the lineage of a subject, comprising:

acquiring a sample of the subject's genomic DNA including at least one genomic repeat sequence;

identifying the at least one genomic repeat sequence;

determining a length of the at least one genomic repeat sequence; and

comparing the length of the at least one genomic repeat sequence with a length of a corresponding repeat sequence of a putative relative of the subject.

15. The method according to claim 14, wherein identifying the at least one genomic repeat sequence comprises:

providing a first oligonucleotide primer and a second oligonucleotide primer; and

conducting a first nucleic acid amplification on the subject's genomic DNA using the first oligonucleotide primer and the second oligonucleotide primer to produce amplified DNA fragments based on repeat sequences on at least one end of the subject's genomic DNA.

16. The method according to claim 15, wherein providing the first oligonucleotide primer comprises providing an oligonucleotide primer including a repeat sequence and a non-repeat nucleotide located on the 5′ end thereof, the non-repeat nucleotide serving to localize the first oligonucleotide primer to the 5′ end of the at least one genomic repeat sequence.

17. The method according to claim 15, wherein providing the second oligonucleotide primer comprises providing an oligonucleotide primer that starts within an amplification-permissive genetic distance on the 3′ side of the at least one genomic repeat sequence.

18. The method according to claim 15, wherein providing the second oligonucleotide primer comprises providing an oligonucleotide primer including at least one non-selective base.

19. The method according to claim 15, wherein providing the second oligonucleotide primer comprises providing an oligonucleotide primer including at least one inosine residue.

20. The method according to claim 15, further comprising:

providing a third oligonucleotide primer and a fourth oligonucleotide primer; and

conducting a second nucleic acid amplification using the third oligonucleotide primer and the fourth oligonucleotide primer on amplified DNA fragments produced by the first nucleic acid amplification to enable a selection of a sub-set of the amplified DNA fragments produced by the first nucleic acid amplification, wherein the third oligonucleotide primer is an elongated version of the first oligonucleotide primer and the fourth oligonucleotide primer is an elongated version of the second oligonucleotide primer.

21. The method according to claim 20, wherein providing the fourth oligonucleotide primer comprises providing an oligonucleotide primer including at least one non-selective base.

22. The method according to claim 20, wherein providing the fourth oligonucleotide primer comprises providing an oligonucleotide primer including at least one inosine residue.

23. The method according to claim 15, further comprising digesting the products of the first nucleic acid amplification with a restriction enzyme to increase the number of genetic polymorphisms detectable in the subject's genomic DNA and to decrease the sizes of the amplified DNA fragments.

24. The method according to claim 20, further comprising digesting the products of the second nucleic acid amplification with a restriction enzyme to increase the number of genetic polymorphisms detectable in the subject's genomic DNA and to decrease the sizes of the products of the second nucleic acid amplification.

25. The method according to claim 15, wherein conducting the first nucleic acid amplification comprises conducting a polymerase chain reaction amplification.

26. The method according to claim 20, wherein conducting the second nucleic acid amplification comprises conducting a polymerase chain reaction amplification.

27. The method according to claim 15, wherein conducting the first nucleic acid amplification comprises conducting the first nucleic acid amplification under stringent conditions.

28. The method according to claim 20, wherein conducting the second nucleic acid amplification comprises conducting the second nucleic acid amplification under stringent conditions.

29. The method according to claim 20, further comprising diluting the products of the first nucleic acid amplification before conducting the second nucleic acid amplification.

30. The method according to claim 15, wherein providing the first oligonucleotide primer comprises providing an oligonucleotide primer selected from the group consisting of SEQ ID NOS: 3-10.

31. The method according to claim 15, wherein providing the second oligonucleotide primer comprises providing an oligonucleotide primer selected from the group consisting of SEQ ID NOS: 11-15.

32. The method according to claim 20, wherein providing the third oligonucleotide primer comprises providing an oligonucleotide primer selected from the group consisting of SEQ ID NOS: 16-21.

33. The method according to claim 20, wherein providing the fourth oligonucleotide primer comprises providing an oligonucleotide primer selected from the group consisting of SEQ ID NOS: 22-27.

34. The method according to claim 14, wherein the putative relative of the subject is a putative parent of the subject.

35. A kit of parts for conducting a first nucleic acid amplification on a subject's genomic DNA that includes at least one genomic repeat sequence, comprising

a first oligonucleotide primer including a non-repeat nucleotide located on the 5′ end thereof and a repeat sequence, the non-repeat nucleotide serving to localize the first oligonucleotide primer to a 5′ end of the at least one genomic repeat sequence; and

a second oligonucleotide primer that starts within an amplification-permissive genetic distance on the 3′ side of the genomic repeat sequence.

36. The kit of parts of claim 35, further comprising the following parts for conducting a second nucleic acid amplification on the products of the first nucleic acid amplification:

a third oligonucleotide primer comprising the sequence of the first oligonucleotide primer together with additional nucleotides; and

a fourth oligonucleotide primer comprising the sequence of the second oligonucleotide primer together with additional nucleotides.

37. The kit of parts of claim 35, wherein the second oligonucleotide primer further comprises at least one non-selective base.

38. The kit of parts of claim 35, wherein the second oligonucleotide primer further comprises at least one inosine residue.

39. The kit of parts of claim 35, further comprising at least one restriction enzyme.

40. The kit of parts of claim 36, further comprising at least one restriction enzyme.

41. The kit of parts of claim 36, wherein at least one of the additional nucleotides of the fourth oligonucleotide primer is a non-selective base.

42. The kit of parts of claim 36, wherein at least one of the additional nucleotides of the fourth oligonucleotide primer is an inosine residue.

43. The kit of parts of claim 35, wherein the first oligonucleotide primer is selected from the group consisting of SEQ ID NOS: 3-10.

44. The kit of parts of claim 35, wherein the second oligonucleotide primer is selected from the group consisting of SEQ ID NOS: 11-15.

45. The kit of parts of claim 36, wherein the third oligonucleotide primer is selected from the group consisting of SEQ ID NOS: 16-21.

46. The kit of parts of claim 36, wherein the fourth oligonucleotide primer is selected from the group consisting of SEQ ID NOS: 22-27.